Immfinity Biotechnologies

Immunity is complicated. Immfinity lets our partners see clearly. We use our T cell epitope sequencing (Tope-seq) system to discover T cell receptor antigens and decode reactivity Our technology is based on real cells. We do functional assays based on directly testing millions of T cell epitopes simultaneously. No guesswork. At Immfinity, we profile off-target autoreactivity to enable TCR engineering with confidence, do multiplexed TCR discovery using libraries of interesting targets instead of picking just one, and perform fine epitope mapping. We de-risk and accelerate early discovery and development in TCR based therapeutics and peptide-coding vaccines, preventing catastrophic failures in the clinic and making sure resources go towards advancing only the best medicines.